Vaccination News

A measles outbreak in Texas has climbed to nearly 60 cases in 3 weeks, with most cases occurring among unvaccinated children, according to state health officials.

The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against five meningococcal serogroups, the company announced.

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ease dengue virus symptoms when given before and after infection.

CDC data show that seasonal influenza activity is significantly elevated across the United States, and that influenza activity is at its highest level in more than 15 years.

In 5 years, COVID-19 has impacted nearly every aspect of life. Although tens of thousands of cases continue to occur each week, the world’s top public health agencies have considered the pandemic phase of COVID-19 to be over for years.

In July of 2022, mpox was declared a Public Health Emergency of International Concern, or PHEIC, by WHO during a surge in infections that led to more than 100,000 cases in 122 countries.

Inconsistent messaging and evolving recommendations surrounding COVID-19 vaccination protocols may have contributed to both hesitancy and fatigue regarding vaccines among patients, according to experts.

A 90-day review of U.S. foreign aid spending ordered by President Donald J. Trump has halted global health programs, including the U.S. President’s Emergency Plan for AIDS Relief and the President’s Malaria Initiative.

The vast majority of people in a study with long COVID had experienced multiple SARS-CoV-2 infections over the course of a 4-year period, researchers reported.